$3.42 Billion is the total value of Nantahala Capital Management's 116 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 42.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $530,256,000 | -11.3% | 2,400,000 | -21.3% | 15.50% | -16.3% |
| CDXS | Sell | CODEXIS INC | $95,951,000 | -12.1% | 4,191,834 | -16.2% | 2.80% | -17.1% |
| SGMS | Sell | SCIENTIFIC GAMES CORPcall | $79,324,000 | -55.8% | 2,059,300 | -52.4% | 2.32% | -58.3% |
| QADA | Sell | QAD INCcl a | $63,895,000 | -18.2% | 959,666 | -22.4% | 1.87% | -22.8% |
| VG | Sell | VONAGE HLDGS CORP | $54,817,000 | -20.9% | 4,637,611 | -13.8% | 1.60% | -25.4% |
| LXFR | Sell | LUXFER HOLDINGS PLC | $46,823,000 | +21.6% | 2,200,347 | -6.1% | 1.37% | +14.8% |
| THC | Sell | TENET HEALTHCARE CORPcall | $45,547,000 | -4.6% | 875,900 | -26.7% | 1.33% | -10.0% |
| CASH | Sell | META FINL GROUP INC | $44,756,000 | -20.5% | 987,784 | -35.9% | 1.31% | -25.0% |
| SBTX | Sell | SILVERBACK THERAPEUTICS INC | $42,697,000 | -21.5% | 992,242 | -17.8% | 1.25% | -25.9% |
| DXPE | Sell | DXP ENTERPRISES INC | $38,119,000 | +11.8% | 1,263,480 | -17.6% | 1.11% | +5.5% |
| FBIO | Sell | FORTRESS BIOTECH INC | $30,368,000 | +10.4% | 8,602,693 | -0.9% | 0.89% | +4.1% |
| IMAX | Sell | IMAX CORP | $29,196,000 | +0.1% | 1,452,523 | -10.2% | 0.85% | -5.6% |
| KROS | Sell | KEROS THERAPEUTICS INC | $28,336,000 | -24.8% | 460,372 | -13.9% | 0.83% | -29.1% |
| IMTX | Sell | IMMATICS N.V | $27,372,000 | +0.9% | 2,441,765 | -2.9% | 0.80% | -4.9% |
| ALTG | Sell | ALTA EQUIPMENT GROUP INC | $26,339,000 | +2.5% | 2,026,045 | -22.1% | 0.77% | -3.3% |
| GDEN | Sell | GOLDEN ENTMT INC | $22,944,000 | -43.2% | 908,323 | -55.3% | 0.67% | -46.4% |
| IMXI | Sell | INTERNATIONAL MNY EXPRESS IN | $22,643,000 | -31.6% | 1,508,518 | -29.3% | 0.66% | -35.5% |
| Sell | AKUMIN INC | $21,366,000 | +22.7% | 5,774,470 | -0.2% | 0.62% | +15.6% | |
| EHTH | Sell | EHEALTH INC | $20,405,000 | -3.6% | 280,562 | -6.4% | 0.60% | -9.1% |
| VMD | Sell | VIEMED HEALTHCARE INC | $19,538,000 | +28.3% | 1,930,590 | -1.1% | 0.57% | +21.0% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $17,436,000 | -11.6% | 5,150,819 | -26.8% | 0.51% | -16.5% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $16,172,000 | -38.8% | 2,882,786 | -14.1% | 0.47% | -42.2% |
| DHX | Sell | DHI GROUP INC | $16,115,000 | +50.0% | 4,810,513 | -0.6% | 0.47% | +41.4% |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $13,560,000 | -12.7% | 1,712,088 | -13.3% | 0.40% | -17.7% |
| APEN | Sell | APOLLO ENDOSURGERY INC | $12,563,000 | +61.4% | 2,279,970 | -0.4% | 0.37% | +52.3% |
| Sell | FALCON MINERALS CORP | $12,072,000 | +8.3% | 2,688,653 | -24.0% | 0.35% | +2.3% | |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $9,849,000 | -35.2% | 7,816,729 | -0.7% | 0.29% | -38.9% |
| LINC | Sell | LINCOLN EDL SVCS CORP | $9,578,000 | -5.2% | 1,494,298 | -3.9% | 0.28% | -10.5% |
| ZGNX | Sell | ZOGENIX INC | $9,234,000 | -9.8% | 473,055 | -7.6% | 0.27% | -14.8% |
| SSKN | Sell | STRATA SKIN SCIENCES INC | $7,655,000 | +9.0% | 4,583,908 | -2.1% | 0.22% | +2.8% |
| HCA | Sell | HCA HEALTHCARE INC | $6,705,000 | -20.6% | 35,600 | -30.6% | 0.20% | -25.2% |
| SRL | Sell | SCULLY ROYALTY LTD | $6,487,000 | +74.0% | 743,953 | -1.2% | 0.19% | +63.8% |
| TFFP | Sell | TFF PHARMACEUTICALS INC | $5,191,000 | -79.4% | 382,553 | -78.3% | 0.15% | -80.6% |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $4,162,000 | -30.6% | 1,213,540 | -37.0% | 0.12% | -34.4% |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $3,824,000 | -26.2% | 608,974 | -19.0% | 0.11% | -30.4% |
| AFI | Sell | ARMSTRONG FLOORING INC | $2,980,000 | -52.1% | 609,349 | -62.6% | 0.09% | -54.9% |
| ACER | Sell | ACER THERAPEUTICS INC | $2,907,000 | +12.1% | 934,755 | -5.6% | 0.08% | +6.2% |
| TBBK | Sell | BANCORP INC DEL | $2,893,000 | -92.3% | 139,629 | -94.9% | 0.08% | -92.7% |
| BCTG | Sell | BCTG ACQUISITION CORP | $1,956,000 | -14.5% | 175,915 | -12.0% | 0.06% | -19.7% |
| ALTGWS | Sell | ALTA EQUIPMENT GROUP INC*w exp 02/14/202 | $1,633,000 | +64.5% | 179,300 | -4.4% | 0.05% | +54.8% |
| CDXS | Sell | CODEXIS INCcall | $1,229,000 | -81.2% | 53,700 | -82.1% | 0.04% | -82.3% |
| SIC | Sell | SELECT INTERIOR CONCEPTS INCcl a | $1,127,000 | -91.7% | 156,573 | -91.8% | 0.03% | -92.2% |
| THC | Sell | TENET HEALTHCARE CORP | $853,000 | -96.2% | 16,408 | -97.1% | 0.02% | -96.4% |
| TSHA | Sell | TAYSHA GENE THERAPIES INC | $750,000 | -64.0% | 36,956 | -53.0% | 0.02% | -66.2% |
| SIGA | Sell | SIGA TECHNOLOGIES INC | $681,000 | -70.8% | 104,702 | -67.4% | 0.02% | -72.2% |
| CYRN | Sell | CYREN LTD | $487,000 | -74.3% | 598,540 | -67.5% | 0.01% | -76.3% |
| MOTS | Exit | MOTUS GI HLDGS INC | $0 | – | -415,501 | -100.0% | -0.01% | – |
| NK | Exit | NANTKWEST INC | $0 | – | -52,771 | -100.0% | -0.02% | – |
| AMCX | Exit | AMC NETWORKS INCcl a | $0 | – | -25,751 | -100.0% | -0.03% | – |
| CVNA | Exit | CARVANA COcl a | $0 | – | -3,843 | -100.0% | -0.03% | – |
| SFTTW | Exit | SHIFT TECHNOLOGIES INC*w exp 10/13/202 | $0 | – | -249,999 | -100.0% | -0.04% | – |
| CURIW | Exit | CURIOSITYSTREAM INC*w exp 10/14/202 | $0 | – | -200,000 | -100.0% | -0.09% | – |
| STRM | Exit | STREAMLINE HEALTH SOLUTIONS | $0 | – | -2,753,599 | -100.0% | -0.13% | – |
| CEREW | Exit | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $0 | – | -283,332 | -100.0% | -0.13% | – |
| PRTY | Exit | PARTY CITY HOLDCO INC | $0 | – | -834,002 | -100.0% | -0.16% | – |
| PAYAW | Exit | PAYA HOLDINGS INC*w exp 10/16/202 | $0 | – | -538,510 | -100.0% | -0.16% | – |
| XELA | Exit | EXELA TECHNOLOGIES INC | $0 | – | -15,168,086 | -100.0% | -0.20% | – |
| SCPL | Exit | SCIPLAY CORPORATIONcl a | $0 | – | -510,122 | -100.0% | -0.22% | – |
| INAQW | Exit | INSU ACQUISITION CORP II*w exp 09/01/202 | $0 | – | -524,964 | -100.0% | -0.25% | – |
| PRCH | Exit | PORCH GROUP INC | $0 | – | -600,000 | -100.0% | -0.25% | – |
| NATR | Exit | NATURES SUNSHINE PRODS INC | $0 | – | -600,409 | -100.0% | -0.28% | – |
| RFL | Exit | RAFAEL HLDGS INC | $0 | – | -389,370 | -100.0% | -0.28% | – |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -14,602,975 | -100.0% | -0.31% | – |
| YTRA | Exit | YATRA ONLINE INC | $0 | – | -5,315,350 | -100.0% | -0.32% | – |
| FTOCU | Exit | FTAC OLYMPUS ACQUISITION CORunit 08/24/2025 | $0 | – | -1,000,000 | -100.0% | -0.34% | – |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -685,704 | -100.0% | -0.35% | – |
| PLCE | Exit | CHILDRENS PL INC | $0 | – | -252,472 | -100.0% | -0.39% | – |
| PAR | Exit | PAR TECHNOLOGY CORP | $0 | – | -202,312 | -100.0% | -0.39% | – |
| CRHM | Exit | CRH MED CORP | $0 | – | -6,892,005 | -100.0% | -0.50% | – |
| JYNT | Exit | JOINT CORP | $0 | – | -693,172 | -100.0% | -0.56% | – |
| EVRI | Exit | EVERI HLDGS INC | $0 | – | -1,363,786 | -100.0% | -0.58% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -5,123,671 | -100.0% | -0.67% | – |
| UPLD | Exit | UPLAND SOFTWARE INC | $0 | – | -501,100 | -100.0% | -0.71% | – |
| CAR | Exit | AVIS BUDGET GROUPcall | $0 | – | -657,700 | -100.0% | -0.76% | – |
| HCA | Exit | HCA HEALTHCARE INCput | $0 | – | -150,000 | -100.0% | -0.76% | – |
| INAQ | Exit | INSU ACQUISITION CORP II | $0 | – | -1,698,075 | -100.0% | -0.82% | – |
| FCFS | Exit | FIRSTCASH INC | $0 | – | -387,189 | -100.0% | -0.84% | – |
| WYND | Exit | WYNDHAM DESTINATIONS INC | $0 | – | -1,117,394 | -100.0% | -1.55% | – |
| VAC | Exit | MARRIOTT VACTINS WORLDWID CO | $0 | – | -384,987 | -100.0% | -1.64% | – |
| DLB | Exit | DOLBY LABORATORIES INC | $0 | – | -770,845 | -100.0% | -2.32% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.